Skip to content
Monday, May 19, 2025
  • Home
  • BCS News
    • Latest from BCS
    • BCS Editorials
    • Obituaries
    • Editors
  • COVID-19
  • BCS Home

Latest News

  • Impella, build it and the evidence will come…?

  • There is benefit to communicating CVD risk with patients: A meta-analysis

  • Patients with heart failure: Virtual wards

  • Cardiac waiting lists: An outlier or some progress? Part V

  • Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation

  • The diagnostic yield of NT-proBNP in a regional heart failure pathway

  • Do patients with minimally symptomatic severe aortic stenosis benefit from TAVI?

  • Latest News News

    Impella, build it and the evidence will come…?

    By Dr Jonathan ShurlockEdited by Dr Nitin Chandra Mohan The results of the DanGer Shock trial were recently presented at the American College of Cardiology…

    CardioNewsUK 15 April 2024
    View More
  • Latest News News

    There is benefit to communicating CVD risk with patients: A meta-analysis

    By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany A meta-analysis from Dr Mina Bakhit (@Mina_Bakhit) and colleagues has explored the role of cardiovascular disease (CVD)…

    CardioNewsUK 8 February 2024
    View More
  • Latest News News

    Patients with heart failure: Virtual wards

    By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany NHS England have published data related to ‘virtual wards’, which since October have been a recommended option…

    CardioNewsUK 7 February 2024
    View More
  • Latest News News

    Cardiac waiting lists: An outlier or some progress? Part V

    By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany Each of our previous reports have described the continued growth of cardiac waiting lists, including when we…

    CardioNewsUK 6 February 2024
    View More
  • Latest News News

    Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation

    By Dr. Florence Mouy Edited by Dr. Ahmed El-Medany The ARTESIA trial (Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation) has…

    CardioNewsUK 5 December 2023
    View More

Featured

  • BCS Editorials Latest News

    European Society of Cardiology Heart Failure Guidelines 2021: What should we be doing in current practice?

    CardioNewsUK 23 December 2021
  • Echocardiogram Hypertension
    BCS Editorials Latest News

    AF screening and thromboembolic risk: How much AF is significant?

    CardioNewsUK 22 December 2021
  • exercise in park
    BCS Editorials

    Exercise as a treatment: do we talk about it enough in Hypertension Management?

    CardioNewsUK 21 December 2021
  • IHD resource BMJ
    Latest News News Society News & Announcements

    Resources on Ischemic Heart Disease

    CardioNewsUK 25 October 2021
  • Year in Cardiology Course
    Latest News News Society News & Announcements

    Year in Cardiology Course

    CardioNewsUK 22 October 2021
  • Health Inequalities by UK region
    COVID-19 News Society News & Announcements

    Inequalities in Health Alliance calls on Prime Minister to reduce health inequalities.

    CardioNewsUK 16 September 2021
  • Graphical-demonstration-of-the-reduction-in-waist-circumference
    Latest News Other Categories Research & Trials Society News & Announcements

    In case you missed it: a summary of the BCS ’21 top 10 trials (Part II)

    CardioNewsUK 17 August 2021
  • Procedure
    COVID-19 Devices Latest News News Other Categories Society News & Announcements

    Anticoagulation of Patients with Mechanical Heart Valves.

    CardioNewsUK 9 August 2021

Image of a heart with myocardial infarction
Latest News News

Impella, build it and the evidence will come…?

CardioNewsUK 15 April 2024

By Dr Jonathan ShurlockEdited by Dr Nitin Chandra Mohan The results of the DanGer Shock trial were recently presented at the American College of Cardiology…

View More Impella, build it and the evidence will come…?
Latest News News

There is benefit to communicating CVD risk with patients: A meta-analysis

CardioNewsUK 8 February 2024

By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany A meta-analysis from Dr Mina Bakhit (@Mina_Bakhit) and colleagues has explored the role of cardiovascular disease (CVD)…

View More There is benefit to communicating CVD risk with patients: A meta-analysis
Latest News News

Patients with heart failure: Virtual wards

CardioNewsUK 7 February 2024

By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany NHS England have published data related to ‘virtual wards’, which since October have been a recommended option…

View More Patients with heart failure: Virtual wards
Latest News News

Cardiac waiting lists: An outlier or some progress? Part V

CardioNewsUK 6 February 2024

By Dr Jonathan Shurlock Edited by Dr. Ahmed El-Medany Each of our previous reports have described the continued growth of cardiac waiting lists, including when we…

View More Cardiac waiting lists: An outlier or some progress? Part V
Latest News News

Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation

CardioNewsUK 5 December 2023

By Dr. Florence Mouy Edited by Dr. Ahmed El-Medany The ARTESIA trial (Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation) has…

View More Apixaban reduces the risk of stroke in device-detected subclinical atrial fibrillation
Latest News News

The diagnostic yield of NT-proBNP in a regional heart failure pathway

CardioNewsUK 4 December 2023

By Dr. Jonathan ShurlockEdited by Dr. Ahmed El-Medany An interesting study in BMJ Open Heart  has explored the diagnostic yield of a regional heart failure referral pathway…

View More The diagnostic yield of NT-proBNP in a regional heart failure pathway
Latest News News

Do patients with minimally symptomatic severe aortic stenosis benefit from TAVI?

CardioNewsUK 1 December 2023

By Dr. Florence Mouy Edited by Dr. Ahmed El-Medany A study by Huded et al has assessed the outcomes of transcatheter aortic valve implantation (TAVI) in…

View More Do patients with minimally symptomatic severe aortic stenosis benefit from TAVI?
Latest News News

Cardiac waiting lists continue to grow: Part IV

CardioNewsUK 31 October 2023

By Dr. Jonathan ShurlockEdited by Dr Saadia Aslamy NHS England have released the latest waiting list figures, for the end of August. These have highlighted a further…

View More Cardiac waiting lists continue to grow: Part IV
Latest News News

Bumetanide shortage: important consideration for community heart failure teams

CardioNewsUK 26 October 2023

By Dr. Jonathan Shurlock The Department for Health and Social Care (DHSC) has issued a medicine supply shortage notification for Bumetanide oral tablet preparations (1mg and…

View More Bumetanide shortage: important consideration for community heart failure teams
Latest News News

Decreasing access to ALS training: unknown impact on outcomes

CardioNewsUK 26 October 2023

By Dr. Jonathan ShurlockEdited by Dr Saadia Aslamy A recently published article in the BMJ laments the removal of Advanced Life Support training at both undergraduate and…

View More Decreasing access to ALS training: unknown impact on outcomes

Posts navigation

Page 1 Page 2 … Page 24 Next page

Video

https://youtu.be/jpDhCKcM7ak

RSS Heart Journal

  • Echocardiographic cardiac damage classification and clinical outcomes in atrial functional mitral regurgitation
  • Age-specific prognosis of acute and steady minor elevations in cardiac troponin among non-acute myocardial infarction inpatients: a large real-world cohort study
  • Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study
  • Prognostic impact of albuminuria in early-stage chronic kidney disease on cardiovascular outcomes: a cohort study
  • Anticoagulants or antiplatelets for secondary prevention of cryptogenic stroke: an updated systematic review and meta-analysis

RSS AHA Journal Feed

  • AhR, IRF5, and HO‐1 Expression in Evaluating Carotid Atherosclerotic Plaque Vulnerability: A Pilot Observational Study
  • Burden of Treatment in Patients With Heart Failure
  • Rationale and Design of the REPEAT Trial: A Multicenter Randomized Trial Comparing Redo Surgical Aortic Valve Replacement to Valve‐in‐Valve Transcatheter Aortic Valve Replacement
  • Synergistic Network Pharmacology: Preclinical Validation and Clinical Safety in Acute Ischemic Stroke
  • Nomogram for Predicting 1‐, 3‐, and 5‐Year Survival in Hemodynamically Significant Aortic Regurgitation: The ARISE Score
UK Cardiology News |
British Cardiovascular Society
✕
BCS Heartbeat

FREE
VIEW